Pharmacy Week in Review: February 9, 2018

Most Popular

Related Articles

Patients who exercise during chemotherapy may have lower levels of fatigue years after cancer treatments.
Cabozantinib (Cabometyx) treatment resulted in tumor shrinkage among patients with refractory thyroid cancer.
A look at the top stories in the world of pharmacy from last week.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.